IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,295,821 | -53.5% | 1,603,477 | -28.1% | 0.00% | -40.0% |
Q2 2023 | $15,694,138 | +119065.8% | 2,229,281 | +3.4% | 0.01% | 0.0% |
Q1 2023 | $13,170 | +53.0% | 2,155,542 | +60.0% | 0.01% | +66.7% |
Q4 2022 | $8,607 | -99.9% | 1,346,919 | -22.5% | 0.00% | -57.1% |
Q3 2022 | $16,654,000 | -16.1% | 1,738,385 | -3.3% | 0.01% | -12.5% |
Q2 2022 | $19,855,000 | +184.2% | 1,798,549 | +286.1% | 0.01% | +300.0% |
Q1 2022 | $6,987,000 | -46.0% | 465,777 | -31.2% | 0.00% | -50.0% |
Q4 2021 | $12,928,000 | -14.8% | 677,207 | +10.1% | 0.00% | -20.0% |
Q3 2021 | $15,173,000 | -6.8% | 615,278 | -1.6% | 0.01% | 0.0% |
Q2 2021 | $16,274,000 | -16.4% | 625,457 | +1.7% | 0.01% | -16.7% |
Q1 2021 | $19,473,000 | -36.5% | 615,058 | -7.0% | 0.01% | -40.0% |
Q4 2020 | $30,687,000 | +62.7% | 661,362 | +15.4% | 0.01% | +42.9% |
Q3 2020 | $18,864,000 | +23.9% | 572,999 | +3.3% | 0.01% | +16.7% |
Q2 2020 | $15,225,000 | -35.7% | 554,672 | -29.8% | 0.01% | -50.0% |
Q1 2020 | $23,664,000 | +32.1% | 790,503 | +22.1% | 0.01% | +71.4% |
Q4 2019 | $17,914,000 | +30.7% | 647,190 | -14.0% | 0.01% | +16.7% |
Q3 2019 | $13,704,000 | -21.9% | 752,939 | +5.2% | 0.01% | -14.3% |
Q2 2019 | $17,554,000 | +5171.5% | 715,908 | +1946.3% | 0.01% | +250.0% |
Q1 2019 | $333,000 | – | 34,986 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |